LD-2 disclosure · 2nd Quarter - Report
GENENTECH
Client
- Name
- GENENTECH
- Location
- District of Columbia · United States of America
Registrant
- Description
- Consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesMedicare/Medicaid
Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs, including Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299). Policies related to the Most Favored Nation Drug Pricing Model.
LobbyistsJOHN MCMANUS
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Issues related to reforming and increasing transparency within the 340B Drug Pricing Program.
LobbyistsJOHN MCMANUS
Covered position (JOHN MCMANUS): Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
Issues related to tax exempt hospitals and charity care. Issues related to the Tax Exempt Hospital Transparency Act (H.R. 9504).
LobbyistsJOHN MCMANUS · ms MARY GRACE DARCEY